DNA vs LABT (Ginkgo Bioworks Holdings Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 28 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
US Market Trading Session Active
Active trading session is live as of 1:22 PM ET. Prices update dynamically and reflect the latest trade records across major US exchanges. Official closing prices settle after 4:00 PM ET.
DNA leads by +8.67% Alpha Spread Today
DNA is trading at -1.88% while LABT is at -10.55% .
Started At
Official opening auction price
Last Recorded Trade Price
Last recorded trade as of 1:22 PM ET
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | DNA | LABT | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -1.88% | -10.55% | DNA +8.67% |
| Net Dollar Move | $-0.20 | $-0.21 | DNA higher move |
| Open Price | $10.38 | $1.97 | Gap: -2.63% vs -1.01% |
| Day High | $10.79 | $2.00 | Session peaks |
| Day Low | $10.10 | $1.78 | Session troughs |
| Intraday Spread | $0.69 | $0.22 | High/Low spread |
| Share Volume | 2.12M | 109.8K | DNA more active |
| Est. Dollar Volume | $22.18M | $195.4K | DNA higher liquidity |
Explore DNA vs LABT Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.